HHV-6A, 6B, and 7: Immunobiology and host response

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 850-874

  Wang, Fu Zhang ^a   Pellett, Philip E ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890663904     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.049     Document Type: Chapter

References (225)

1. Ablashi, D. V., Balachandran, N., Josephs, S. F. et al. (1991). Genomic polymorphism, growth properties, and immunologic varia-tions in human herpesvirus-6 isolates. Virology, 184, 545-552.
2. Ablashi, D. V., Lapps, W., Kaplan, M., Whitman, J. E., Richert, J. R., and Pearson, G. R. (1998). Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: A preliminary report. Mult. Scler., 4(6), 490-496.
3. Ablashi, D. V., Eastman, H. B., Owen, C. B. et al. (2000). Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol., 16(3), 179-191.
4. Adler, S. P., McVoy, M., Chou, S., Hempfiing, S., Yamanishi, K., and Britt, W. (1993). Antibodies induced by a primary cytomegalovirus infection react with human herpesvirus 6 proteins. J. Infect. Dis., 168, 1119-1126.
5. Anderson, R. A. and Gompels, U. A. (1999). N-and C-terminal exter-nal domains of human herpesvirus-6 glycoprotein H affect a fusion-associated conformation mediated by glycoprotein L binding theN terminus. J. Gen. Virol., 80, 1485-1494.
6. Anderson, R. A., Liu, D. X., and Gompels, U. A. (1996). Definition of a human herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycopro-tein gL: Substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virology, 217(2), 517-526.
7. Arena, A., Liberto, M. C., Capozza, A. B., and Foca, A. (1997). Produc-tive HHV-6 infection in differentiated U937 cells: Role of TNF alpha in regulation of HHV-6. New Microbiol., 20(1), 13-20.
8. Arena, A., Liberto, M. C., Iannello, D., Capozza, A. B., and Foca, A. (1999). Altered cytokine production after human herpes virus type 6 infection. N. Microbiol., 22(4), 293-300.
9. Arena, A., Merendino, R. A., Bonina, L., Iannello, D., Stassi, G., and Mastroeni, P. (2000). Role of IL-15 on monocytic resistance to human herpesvirus 6 infection. N. Microbiol., 23(2), 105-112.
10. Arsenault, S., Gravel, A., Gosselin, J., and Flamand, L. (2003). Gener-ation and characterization of a monoclonal antibody specific for human herpesvirus 6 variant A immediate-early 2 protein. J. Clin. Virol., 28(3), 284-290.
11. Arvin, A., Sharp, M., Smith, S., et al. (1991). Equivalent recognition of varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol., 146, 257-264.
12. Asada, H., Yalcin, S., Balachandra, K., Higashi, K., and Yamanishi, K. (1989). Establishment of titration system for human her-pesvirus 6 and evaluation of neutralizing antibody response to the virus. J. Clin. Microbiol., 27, 2204-2207.
13. Asada, H., Klaus-Kovtun, V., Golding, H., Katz, S. I., and Blauvelt, A. (1999). Human herpesvirus 6 infects dendritic cells and sup-presses human immunodeficiency virus type 1 replication in coinfected cultures. J. Virol., 73(5), 4019-4028.
14. Atedzoe, B. N., Ahmad, A., and Menezes, J. (1997). Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol., 159(10), 4966-4972.
15. Balachandra, K., Ayuthaya, P. I., Auwanit, W. et al. (1989). Prevalence of antibody to human herpesvirus 6 in women and children. Microbiol. Immunol., 33(6), 515-518.
16. Balachandra, N., Amelse, R. E., Zhou, W. W., and Chang, C. K. (1989). Identification of proteins specific for human herpesvirus 6-infected human T cells. J. Virol., 63, 2835-2840.
17. Berneman, Z. N., Ablashi, D. V., Li, G. et al. (1992). Human her-pesvirus 7 is a T-lymphotropic virus and is related to, but sig-nificantly different from, human herpesvirus 6 and human cytomegalovirus. Proc. Natl Acad. Sci. USA, 89(21), 10552-10556.
18. Black, J. B. and Pellett, P. E. (1999). Human herpesvirus 7. Rev. Med. Virol., 9, 245-262.
19. Black, J. B., Sanderlin, K. C., Goldsmith, C. S., Gary, H. E., Lopez, C., and Pellett, P. E. (1989). Growth properties of human herpesvirus-6 strain Z29. J. Virol. Methods, 26, 133-145.
20. Black, J. B., Lopez, C., and Pellett, P. E. (1992). Induction of host cell protein synthesis by human herpesvirus 6. Virus Res., 22(1), 13-23.
21. Black, J. B., Durigon, E., Kite-Powell, K. et al. (1996a). Seroconver-sion to human herpesvirus 6 and human herpesvirus 7 among Brazilian childrenwith clinical diagnoses of measles orrubella. Clin. Infect. Dis., 23, 1156-1158.
22. Black, J. B., Schwarz, T. F., Patton, J. L. et al. (1996b). Evaluation of immunoassays for detection of antibodies to human her-pesvirus 7. Clin. Diagn. Lab. Immunol., 3, 79-83.
23. Boeckh, M. and Nichols, W. S. (2003). Immunosuppressive effects of beta-herpesviruses. Herpes, 10(1), 12-16.
24. Boutolleau, D., Fernandez, C., Andre, E. et al. (2003). Human her-pesvirus (HHV)-6 and HHV-7: Two closely related viruses with different infection profiles in stem cell transplantation recipi-ents. J. Infect. Dis., 187(2), 179-186.
25. Braun, D. K., Dominguez, G., and Pellett, P. E. (1997). Human her-pesvirus 6. Clin. Microbiol. Rev., 10, 521-567.
26. Burd, E. M. and Carrigan, D. R. (1993). Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes. Virus Res., 29, 79-90.
27. Burd, E. M., Knox, K. K., and Carrigan D. R. (1993). Human herpesvirus-6-associated suppression of growth factor-induced macrophage maturation in human bone marrow cul-tures. Blood, 81, 1645-1650.
28. Campadelli-Fiume, G., Guerrini, S., Liu, X., and Foa-Tomasi, L. (1993). Monoclonal antibodies to glycoprotein B differentiate human herpesvirus 6 into two clusters, variants A and B. J. Gen. Virol., 74, 2257-2262.
29. Carricart, S. E., Bustos, D., Biganzoli, P., Nates, S. E., and Pavan, J. V. (2004). Isotype immune response of IgG antibodies at the persistence and reactivation stages of human herpes virus 6 infection. J. Clin. Virol., 31(4), 266-269.
30. Carrigan, D. R. (1995). Human herpesvirus-6 and bone marrow transplantation. Blood, 85(1), 294-295.
31. Caruso, A., Rotola, A., Comar, M. et al. (2002). HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinfiammatory chemokines. J. Med. Virol., 67(4), 528-533.
32. Caruso, A., Favilli, F., Rotola, A. et al. (2003). Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. J. Med. Virol., 70(3), 451-458.
33. Caselli, E., Boni, M., Bracci, A. et al. (2002). Detection of antibod-ies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis. J. Clin. Microbiol., 40(11), 4131-4137.
34. Caserta, M. T., Hall, C. B., Schnabel, K., Long, C. E., and D'Heron, N. (1998). Primary human herpesvirus 7 infection: A comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J. Pediatr., 133(3), 386-389.
35. Caserta, M. T., Mock, D. J., and Dewhurst, S. (2001). Human her-pesvirus 6. Clin. Infect. Dis., 33(6), 829-833.
36. Cermelli, C., Concari, M., Carubbi, F. et al. (1996). Growth of human herpesvirus 6 in HEPG2 cells. Virus Res., 45, 75-85.
37. Cermelli, C., Berti, R., Soldan, S. S. (2003). et al. High fre-quency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J. Infect. Dis., 187(9), 1377-1387.
38. Cesarman, E. and Knowles, D. M. (1999). The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lympho-proliferative diseases. Semin. Cancer. Biol., 9(3), 165-174.
39. Chandran, B., Tirawatnapong, S., Pfeiffer, B. and Ablashi, D. V. (1992). Antigenic relationships among human herpesvirus-6 isolates. J. Med. Virol., 37(4), 247-254.
40. Chapenko, S., Millers, A., Nora, Z., Logina, I., Kukaine, R., and Murovska, M. (2003). Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol., 69(1), 111-117.
41. Cirone, M., Campadelli-Fiume, G., Foa-Tomasi, L., Torrisi, M. R., and Faggioni, A. (1994). Human herpesvirus 6 envelope glyco-proteins B and H-L complex are undetectable on the plasma membrane of infected lymphocytes. AIDS Res. Hum. Retro-viruses, 10(2), 175-179.
42. Cirone, M., Cuomo, L., Zompetta, C. et al. (2002). Human her-pesvirus 6 and multiple sclerosis: A study of T cell cross-reactivity to viral and myelin basic protein antigens. J. Med. Virol., 68(2), 268-272.
43. Clark, D. A. (2000). Human herpesvirus 6. Rev. Med. Virol., 10(3), 155-173.
44. Clark, D. A., and Griffiths, P. D. (2003). Human herpesvirus 6: Rel-evance of infection in the immunocompromised host. Br. J. Haematol., 120(3), 384-395.
45. Clark, D. A., Ait-Khaled, M., Wheeler, A. C. et al. (1996). Quantifi-cation of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR. J. Gen. Virol., 77, 2271-2275.
46. Cone, R. W., Huang, M. L., Hackman, R. C., and Corey, L. (1996). Coinfection with human herpesvirus 6 variants A and B in lung tissue. J. Clin. Microbiol., 34, 877-881.
47. Dahl, H., Fjaertoft, G., Norsted, T., Wang, F. Z., Mousavi-Jazi, M., and Linde, A. (1999). Reactivation of human herpesvirus 6 during pregnancy. J. Infect. Dis., 180(6), 2035-2038.
48. DesJardin, J. A., Gibbons, L., Cho, E. et al. (1998). Human her-pesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J. Infect. Dis., 178(6), 1783-1786.
49. DesJardin, J. A., Cho, E., Supran, S., Gibbons, L., Werner, B. G., and Snydman, D. R. (2001). Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopicliver transplant recipients. Clin. Infect. Dis., 33(8), 1358-1362.
50. Dewin, D. R., Catusse, J., and Gompels, U. A. (2000). Identification and characterization of U83A viral chemokine, a broad and potent beta-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform. J. Immunol.176(1), 544-556.
51. Dhepakson, P., Mori, Y., Jiang, Y. B. et al. (2002). Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J. Gen. Virol., 83(4), 847-854.
52. Dockrell, D. H., Mendez, J. C., Jones, M. et al. (1999). Human her-pesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation, 67(3), 399-403.
53. Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., and Pellett, P. E. (1999). Human her-pesvirus 6B genome sequence: Coding content and com-parison with human herpesvirus 6A. J. Virol., 73, 8040-8052.
54. Eizuru, Y. and Minamishima, Y.(1992). Evidence forputative imme-diate early antigens in human herpesvirus 6-infected cells. J. Gen. Virol., 73, 2161-2165.
55. Emery, V. C., Atkins, M. C., Bowen, E. F. et al. (1999). Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: Evidence for increased human immunodefi-ciency viral load in the presence of human herpesvirus 6. J. Med. Virol., 57(3), 278-282.
56. Enbom, M., Martin, C., Fredrikson, S., Jagdahl, L., Dahl, H., and Linde, A. (1997). Intrathecal antibody production to lym-photropic herpesviruses in patients with multiple sclerosis. Neurol. Infect. Epidemiol., 2, 107-111.
57. Enbom, M., Wang, F. Z., Fredrickson, S., Martin, C., Dahl, H., and Linde, A. (1999). Similar humoral and cellular immunologi-cal reactivities to human herpesvirus 6 in patients with mul-tiple sclerosis and controls. Clin. Diagn. Lab. Immunol., 6, 545-549.
58. Feldstein, A. E., Razonable, R. R., Boyce, T. G. et al. (2003). Preva-lence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr. Transpl., 7(2), 125-129.
59. Flamand, L., Gosselin, J., D'Addario, M. et al. (1991). Human her-pesvirus 6 induces interleukin-1 beta and tumor necrosis fac-tor alpha, but not interleukin-6, in peripheral blood mononu-clear cell cultures. J. Virol., 65(9), 5105-5110.
60. Flamand, L., Gosselin, J., Stefanescu, I., Ablashi, D., and Menezes, J. (1995). Immunosuppressive effect of human herpesvirus 6 on T-cell functions: Suppression of interleukin-2 synthesis and cell proliferation [published erratum appears in Blood, 86, 418, 1995]. Blood, 85(5), 1263-1271.
61. Flamand, L., Stefanescu, I., and Menezes, J. (1996). Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest., 97, 1373-1381.
62. Flamand, L., Romerio, F., Reitz, M. S., and Gallo, R. C. (1998). CD4 promoter transactivation by human herpesvirus 6. J. Virol., 72(11), 8797-8805.
63. Flebbe-Rehwaldt, L. M., Wood, C., and Chandran, B. (2000). Char-acterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early regionB U16-U17 open reading frames. J. Virol., 74(23), 11040-11054.
64. Foa-Tomasi, L., Boscaro, A., Di Gaeta, S., and Campadelli-Fiume, G. (1991). Monoclonal antibodies to gp100 inhibit penetration of human herpesvirus 6 and polykaryocyte formation in sus-ceptible cells. J. Virol., 65, 4124-4129.
65. Foa-Tomasi, L., Guerrini, S., Huang, T., and Campadelli-Fiume, G. (1992). Characterization of human herpesvirus-6 (U1102) and (GS) gp112 and identification of the Z29-specified homolog. Virology, 191, 511-516.
66. Foa-Tomasi, L., Avitabile, E., Ke, L., and Campadelli-Fiume, G. (1994). Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6. J. Gen. Virol., 75, 2719-2727.
67. Foa-Tomasi, L., Fiorilli, M. P., Avitabile, E., and Campadelli-Fiume, G. (1996). Identification of an 85 kDa phosphoprotein as an immunodominant protein specific for human herpesvirus 7-infected cells. J. Gen. Virol., 77, 511-518.
68. Fox, J. D., Briggs, M., Ward, P. A., and Tedder, R. S. (1990). Human herpesvirus 6 in salivary glands. Lancet, 336(8715), 590-593.
69. Franti, M., Aubin, J. T., Saint-Maur, G. et al. (2002). Immune reactiv-ity of human sera to the glycoprotein B of human herpesvirus 7. J. Clin. Microbiol., 40(1), 44-51.
70. Frenkel, N., Schirmer, E. C., Katsafanas, G., and June, C. H. (1990). T-cell activation is required for efficient replication of human herpesvirus 6. J. Virol., 64(9), 4598-4602.
71. Furukawa, M., Yasukawa, M., Yakushijin, Y., and Fujita S. (1994). Distinct effects of human herpesvirus 6 and human her-pesvirus 7 on surface molecule expression and function of CD4+ T cells. J. Immunol., 152, 5768-5775.
72. Gobbi, A., Stoddart, C. A., Malnati, M. S. et al. (1999). Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J. Exp. Med., 189(12), 1953-1960.
73. Goodman, A. D., Mock, D. J., Powers, J. M., Baker, J. V., and Blumberg, B. M. (2003). Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J. Infect. Dis., 187(9), 1365-1376.
74. Griffiths, P. D. (2003). The indirect effects of virus infections. Rev. Med. Virol., 13, 1-3.
75. Griffiths, P. D., Ait-Khaled, M., Bearcroft, C. P. et al. (1999). Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus. J. Med. Virol., 59(4), 496-501.
76. Grivel, J. C., Ito, Y., Faga, G. et al. (2001). Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by human her-pesvirus 6. Nat. Med., 7(11), 1232-1235.
77. Grivel, J. C., Santoro, F., Chen, S. et al. (2003). Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J. Virol., 77(15), 8280-8289.
78. Hall, C. B., Long, C. E., Schnabel, K. C. et al. (1994). Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N. Engl. J. Med., 331(7), 432-438.
79. Harma, M., Hockerstedt, K., and Lautenschlager, I. (2003). Human herpesvirus-6 and acute liver failure. Transplantation, 76(3), 536-539.
80. Hasegawa, A., Yasukawa, M., Sakai, I., and Fujita, S. (2001). Tran-scriptional down-regulation of CXC chemokine receptor 4 induced by impairedassociation of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J. Immunol., 166(2), 1125-1131.
81. He, J., McCarthy, M., Zhou, Y., Chandran, B., and Wood, C. (1996). Infection of primary human fetal astrocytes by human her-pesvirus 6. J. Virol., 70, 1296-1300.
82. Hidaka, Y., Okada, K., Kusuhara, K., Miyazaki, C., Tokugawa, K., and Ueda, K. (1994). Exanthem subitum and human herpesvirus 7 infection. Pediatr. Infect. Dis. J., 13(11), 1010-1011.
83. Hirata, Y., Kondo, K., and Yamanishi, K. (2001). Human herpesvirus 6 downregulates major histocompatibility complex class I in dendritic cells. J. Med. Virol., 65(3), 576-583.
84. Horvat, R. T., Parmely, M. J., and Chandran, B. (1993). Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J. Infect. Dis., 167(6), 1274-1280.
85. Huang, L. M., Lee, C. Y., Liu, M. Y., and Lee, P. I. (1997). Primary infections of human herpesvirus-7 and human herpesvirus-6: A comparative, longitudinal study up to 6 years of age. Acta Paediatr., 86, 604-608.
86. Hudson, A. W., Howley, P. M., and Ploegh, H. L. (2001). A human herpesvirus 7 glycoprotein, U21, diverts major histocompati-bility complex class I molecules to lysosomes. J. Virol., 75(24), 12347-12358.
87. Hudson, A. W., Blom, D., Howley, P. M., and Ploegh, H. L. (2003). The ER-lumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic, 4(12), 824-837.
88. Humar, A., Malkan, G., Moussa, G., Greig, P., Levy, G., and Mazzulli, T. (2000). Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J. Infect. Dis., 181(4), 1450-1453.
89. Humar, A., Kumar, D., Caliendo, A. M. et al. (2002). Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation, 73(4), 599-604.
90. Ichimi, R., Jin-no, T., and Ito, M. (1999). Induction of apoptosis in cord blood lymphocytes by HHV-6. J. Med. Virol., 58(1), 63-68.
91. Inoue, Y., Yasukawa, M., and Fujita, S. (1997). Induction of T-cell apoptosis by human herpesvirus 6. J. Virol., 71, 3751-3759.
92. Isegawa, Y., Ping, Z., Nakano, K., Sugimoto, N., and Yamanishi, K. (1998). Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol., 72(7), 6104-6112.
93. Isomura, H., Yamada, M., Yoshida, M. et al. (1997). Suppressive effects of human herpesvirus 6 on in vitro colony forma-tion of hematopoietic progenitor cells. J. Med. Virol., 52(4), 406-412.
94. Isomura, H., Yoshida, M., Namba, H., and Yamada, M. (2003). Inter-action of human herpesvirus 6with human CD34 positive cells. J. Med. Virol., 70(3), 444-450.
95. Iyengar, S., Levine, P. H., Ablashi, D., Neequaye, J., and Pearson, G. R. (1991). Sero-epidemiological investigations on human her-pesvirus 6 (HHV-6) infections using a newly developed early antigen assay. Int. J. Cancer, 49, 551-557.
96. Jacobs, F., Knoop, C., Brancart, F. et al. (2003). Human herpesvirus-6 infectionafter lung and heart-lungtransplantation: A prospec-tive longitudinal study. Transplantation, 75(12), 1996-2001.
97. Kakimoto, M., Hasegawa, A., Fujita, S., and Yasukawa, M. (2002). Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J. Virol., 76(20), 10338-10345.
98. Kano, Y., Inaoka, M., and Shiohara, T. (2004). Association between anticonvulsant hypersensitivity syndrome and human her-pesvirus 6 reactivation and hypogammaglobulinemia. Arch. Dermatol., 140(2), 183-188.
99. Kempf, W., Adams, V., Wey, N. et al. (1997). CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B. Proc. Natl Acad. Sci. USA, 94, 7600-7605.
100. Kempf, W., Adams, V., Mirandola, P. et al. (1998). Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen. J. Infect. Dis., 178(3), 841-845.
101. Kidd, I. M., Clark, D. A., Sabin, C. A. et al. (2000). Prospective study of human betaherpesviruses after renal transplantation: Associa-tion of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Trans-plantation, 69(11), 2400-2404.
102. Kikuta, H., Lu, H., Tomizawa, K., and Matsumoto, S. (1990a). Enhancement of human herpesvirus 6 replication in adult human lymphocytes by monoclonal antibody to CD3. J. Infect. Dis., 161(6), 1085-1087.
103. Kikuta, H., Nakane, A., Lu, H., Taguchi, Y., Minagawa, T., and Matsumoto, S. (1990b). Interferon induction by human her-pesvirus 6 in human mononuclear cells. J. Infect. Dis., 162(1), 35-38.
104. Knox, K. K., and Carrigan, D. R. (1992). In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J. Infect. Dis., 165(5), 925-929.
105. Kondo, K., Kondo, T., Okuno, T., Takahashi, M., and Yamanishi, K. (1991). Latent human herpesvirus 6 infection of human mono-cytes/macrophages. J. Gen. Virol., 72, 1401-1408.
106. Kondo, K., Xu, J., and Mocarski, E. S. (1996). Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive indi-viduals. Proc. Natl Acad. Sci. USA, 93(20), 11137-11142.
107. Kondo, K., Kondo., T., Shimada, K., Amo, K., Miyagawa, H., and Yamanishi, K. (2002a). Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J. Med. Virol., 67(3), 364-369.
108. Kondo, K., Shimada, K., Sashihara, J., Tanaka-Taya, K., and Yaman-ishi, K. (2002b). Identification of human herpesvirus 6 latency-associated transcripts. J. Virol., 76(8), 4145-4151.
109. Kong, H., Baerbig, Q., Duncan, L., Shepel, N., and Mayne, M. (2003). Human herpesvirus type 6 indirectly enhances oligodendro-cyte cell death. J. Neurovirol.9(5), 539-550.
110. Kositanont, U., Wasi, C., Wanprapar, N. et al. (1999). Primary infec-tion of human herpesvirus 6 in children with vertical infection of human immunodeficicncy virus type 1. J. Infect. Dis., 180, 50-55.
111. Kumagai, T., Yoshikawa, T., Yoshida, M. et al. (2006). Time course characteristics of human herpesvirus 6 specific cel-lular immune response and natural killer cell activity in patients with exanthema subitum. J. Med. Virol., 78(6), 792-799.
112. LaCroix, S., Stewart, J. A., Thouless, M. E., and Black, J. B. (2000). An immunoblot assay for detection of immunoglobulin M anti-body to human herpesvirus 6. Clin. Diagn. Lab. Immunol., 7(5), 823-827.
113. Landini, M. P., Lazzarotto, T., Xu, J., Geballe, A. P., and Mocarski, E. S. (2000). Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. Biol. Blood Marrow Transpl., 6(2), 100-108.
114. Lautenschlager, I., Harma, M., Hockerstedt, K., Linnavuori, K., Logi-nov, R., and Taskinen, E. (2002). Human herpesvirus-6 infec-tion is associated with adhesion molecule induction and lym-phocyte infiltration in liver allografts. J. Hepatol., 37(5), 648-654.
115. Li, C., Goodrich, J. M., and Yang, X. (1997). Interferon-gamma (IFN-gamma) regulates production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected monocyte/macrophage lin-eage. Clin. Exp. Immunol., 109(3), 421-425.
116. Linde, A., Dahl, H., Wahren, B., Fridell, E., Salahuddin, Z., and Biberfeld, P. (1988). IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infec-tions and cytomegalovirus infections. J. Virol. Methods, 21, 117-123.
117. Littler, E., Lawrence, G., Liu, M. Y., Barrell, B. G., and Arrand, J. R. (1990). Identification, cloning, and expression of the major capsid protein gene of human herpesvirus 6. J. Virol., 64, 714-722.
118. Liu, D. X., Gompels, U. A., Foa-Tomasi, L., and Campadelli-Fiume, G. (1993a). Human herpesvirus-6 glycoprotein H and L homologs are components of the GP100 complex and the GH external domain is the target for neutralizing monoclonal antibodies. Virology, 197, 12-22.
119. Liu, D. X., Gompels, U. A., Nicholas, J., and Lelliott, C. (1993b). Iden-tification and expression of the human herpesvirus 6 glycopro-tein H and interaction with an accessory 40K glycoprotein. J. Gen. Virol., 74, 1847-1857.
120. Ljungman, P. (2002). Beta-herpesvirus challenges in the transplant recipient. J. Infect. Dis., 186 Suppl. 1, S99-S109.
121. Ljungman, P., Wahren, B., and Sundqvist, V. A. (1985). Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase. J. Virol. Method., 12, 199-208.
122. Lowance, D., Neumayer, H. H., Legendre, C. M. et al. (1999). Valacy-clovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N. Engl. J. Med., 340(19), 1462-1470.
123. Luppi, M., Barozzi, P., Morris, C., et al. (1999). Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J. Virol., 73(1), 754-759.
124. Lusso, P., De Maria, A., Malnati, M. et al. (1991a). Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lym-phocytes by human herpesvirus 6. Nature, 349(6309), 533-535.
125. Lusso, P., Malnati, M., De Maria, A. et al. (1991b). Productive infec-tion of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J. Immunol.147, 685-691.
126. Lusso, P., Malnati, M. S., Garzino-Demo, A., Crowley, R. W., Long, E. O., and Gallo, R. C. (1993). Infection of natural killer cells by human herpesvirus 6. Nature, 362(6419), 458-462.
127. Lusso, P., Secchiero, P., Crowley, R. W., Garzino-Demo, A., Berne-man, Z. N., and Gallo, R. C. (1994). CD4 is a critical compo-nent of the receptor for human herpesvirus 7: Interference with human immunodeficiency virus. Proc. Natl Acad. Sci. USA, 91, 3872-3876.
128. Lusso, P., Garzino-Demo, A., Crowley, R. W., and Malnati, M. S. (1995). Infection of gamma/delta T lymphocytes by human herpesvirus 6: Transcriptional induction of CD4 and sus-ceptibility to HIV infection. J. Exp. Med., 181(4), 1303-1310.
129. Luttichau, H. R., Clark-Lewis, I., Jensen, P. O., Moser, C., Ger-stoft, J., and Schwartz, T. W. (2003). A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. J. Biol. Chem., 278(13), 10928-10933.
130. Malnati, M. S., Lusso, P., Ciccone, E., Moretta, A., Moretta, L., and Long, E. O. (1993). Recognition of virus-infected cells by nat-ural killer cell clones is controlled by polymorphic target cell elements. J. Exp. Med., 178(3), 961-969.
131. Mayne, M., Cheadle, C., Soldan, S. S. et al. (2001). Gene expres-sion profile of herpesvirus-infected T cells obtained using immunomicroarrays: Induction of proinfiammatory mecha-nisms. J. Virol., 75(23), 11641-11650.
132. Meeuwsen, S., Persoon-Deen, C., Bsibsi, M. et al. (2005). Modu-lation of the cytokine network in human adult astrocytes by human herpesvirus-6A. J. Neuroimmunol., 164(1-2), 37-47.
133. Milne, R. S., Mattick, C., Nicholson, L., Devaraj, P., Alcami, A., and Gompels, U. A. (2000). RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J. Immunol., 164(5), 2396-2404.
134. Mirandola, P., Secchiero, P., Pierpaoli, S. et al. (2000). Infection of CD34(+) hematopoietic progenitor cells by human her-pesvirus 7 (HHV-7). Blood, 96(1), 126-131.
135. Miyoshi, H., Tanaka-Taya, K., Hara, J. et al. (2001). Inverse relation-ship between human herpesvirus-6 and-7 detection after allo-geneic and autologous stem cell transplantation. Bone Marrow Transpl., 27(10), 1065-1070.
136. Molden, J., Chang, Y., You, Y., Moore, P. S., and Goldsmith, M. A. (1997). A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem., 272(31), 19625-19631.
137. Mori, Y., Seya, T., Huang, H. L., Akkapaiboon, P., Dhepakson, P., and Yamanishi, K. (2002). Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J. Virol., 76(13), 6750-6761.
138. Mori, Y., Akkapaiboon, P., Yang, X., and Yamanishi, K. (2003a). The human herpesvirus 6 U100 gene product is the third compo-nent of the gH-gL glycoprotein complex on the viral envelope. J. Virol., 77(4), 2452-2458.
139. Mori, Y., Yang, X., Akkapaiboon, P., Okuno, T., and Yamanishi, K. (2003b). Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complexassociates with human CD46. J. Virol., 77(8), 4992-4999.
140. Nakagawa, N., Mukai, T., Sakamoto, J. et al. (1997). Antigenic analy-sis of human herpesvirus 7 (HHV-7) and HHV-6 using immune sera and monoclonal antibodies against HHV-7. J. Gen. Virol., 78, 1131-1137.
141. Nakano, K., Tadagaki, K., Isegawa, Y., Aye, M. M., Zou, P., and Yaman-ishi, K. (2003). Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol., 77(14), 8108-8115.
142. Neipel, F., Ellinger, K., and Fleckenstein, B. (1992). Gene for the major antigenic structural protein (p100) of human her-pesvirus 6. J. Virol., 66, 3918-3924.
143. Ohashi, M., Yoshikawa, T., Ihira, M. et al. (2002). Reactivation of human herpesvirus 6 and7 in pregnant women. J. Med. Virol., 67(3), 354-358.
144. Okuno, T., Sao, H., Asada, H., Shiraki, K., Takahashi, M., and Yaman-ishi, K. (1990). Analysis of a glycoprotein for human her-pesvirus 6 (HHV-6) using monoclonal antibodies. Virology, 176, 625-628.
145. Okuno, T., Shao, H., Asada, H., Shiraki, K., Takahashi, M., and Yamanishi, K. (1992). Analysis of human herpesvirus 6 glyco-proteins recognized by monoclonal antibody OHV1. J. Gen. Virol., 73, 443-447.
146. Oliveira, S. A., Turner, D. J., Knowles, W., Nascimento, J. P., Brown, D. W., and Ward, K. N. (2003). Primary human herpesvirus-6 and-7 infections, often coinciding, misdiagnosed as measles in children from a tropical region of Brazil. Epidemiol. Infect., 131(2), 873-879.
147. Osman, H. K. E., Peiris, J. S. M., Taylor, C. E., Warwicker, P., Jarrett, R. F., and Madeley, C. R. (1996). “Cytomegalovirus disease” in renal allograft recipients: Is human herpesvirus 7a cofactor for disease progression? J. Med. Virol., 48, 295-301.
148. Oster, B., Bundgaard, B., and Hollsberg, P. (2005). Human her-pesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells. J. Virol., 79(3), 1961-1965.
149. Patnaik, M., Komaroff, A. L., Conley, E., Ojo-Amaize, E. A., and Peter, J. B.(1995). Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syn-drome. J. Infect. Dis., 172, 1264-1267.
150. Pellett, P. E., Sanchez-Martinez, D., Dominguez, G. et al. (1993). A strongly immunoreactive virion protein of human herpesvirus 6 variant B strain Z29: Identification and characterization of the gene and mapping of a variant-specific monoclonal antibody reactive epitope. Virology, 195(2), 521-531.
151. Qian, G., Wood, C., and Chandran, B. (1993). Identification and characterization of glycoprotein gH of human herpesvirus-6. Virology, 194(1), 380-386.
152. Rapp, J. C., Krug, L. T., Inoue, N., Dambaugh, T. R., and Pellett, P. E. (2000). U94, the human herpesvirus 6 homolog of the par-vovirus nonstructuralgene, ishighly conservedamong isolates and is expressed at low mRNA levels as a spliced transcript. Virology, 268, 504-516.
153. Razvi, E. S. and Welsh, R. M. (1995). Apoptosis in viral infections. Adv. Virus Res. 45, 1-60.
154. Robert, C., Aubin, J. T., Visse, B., Fillet, A. M., Huraux, J. M., and Agut, H. (1996). Difference in permissiveness of human fibroblast cells to variants A and B of human herpesvirus-6. Res. Virol., 147(4), 219-225.
155. Roffman, E. and Frenkel, N. (1990). Interleukin-2 inhibits the repli-cation of human herpesvirus-6 in mature thymocytes. Virol-ogy, 175(2), 591-594.
156. Roffman, E. and Frenkel, N. (1991). Replication of human herpesvirus-6 in thymocytes activated by anti-CD3 antibody. J. Infect. Dis., 164, 617-618.
157. Rogers, J., Rohal, S., Carrigan, D. R. et al. (2000). Human herpesvirus-6 in liver transplant recipients: Role in pathogen-esis of fungal infections, neurologic complications, and out-come. Transplantation, 69(12), 2566-2573.
158. Rossi, C., Delforge, M. L., Jacobs, F. et al. (2001). Fatal primary infec-tion due to human herpesvirus 6 variant A ina renal transplant recipient. Transplantation, 71(2), 288-292.
159. Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E., and Di Luca, D. (1998). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl Acad. Sci. USA, 95(23), 13911-13916.
160. Roush, K. S., Domiati-Saad, R. K., Margraf, L. R. et al. (2001). Preva-lence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue. Am. J. Clin. Pathol., 116(5), 648-654.
161. Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A., and Lusso, P. (1999). CD46 is a cellular receptor from human herpesvirus 6. Cell, 99, 817-827.
162. Santoro, F., Greenstone, H. L., Insinga, A. et al. (2003). Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J. Biol. Chem., 278(28), 25964-25969.
163. Secchiero, P., Flamand, L., Gilbellini, D. et al. (1997). Human herpesvirus 7 induces CD4+ T-cell death by two distinct mechanisms: Necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. Blood, 90, 4502-4512.
164. Secchiero, P., Bertolaso, L., Casareto, L. et al. (1998a). Human her-pesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidiza-tion of CD4(+) T cells. Blood, 92(5), 1685-1696.
165. Secchiero, P., Bertolaso, L., Gibellini, D. et al. (1998b). Enforced expression of human bcl-2 in CD4+ T cells enhances human herpesvirus 7 replication and induction of cytopathic effects. Eur. J. Immunol.28(5), 1587-1596.
166. Secchiero, P., Zella, D., Barabitskaja, O. et al. (1998c). Progressive and persistent downregulation of surface CXCR4 in CD4(+)T cells infected with human herpesvirus 7. Blood, 92(12), 4521-4528.
167. Secchiero, P., Mirandola, P., Zella, D. et al. (2001). Human her-pesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4(+) T cells. Blood, 98(8), 2474-2481.
168. Shiraki, K., Okuno, T., Yamanishi, K., and Takahashi, M. (1989). Virion and nonstructural polypeptides of human herpesvirus-6. Virus. Res., 13, 173-178.
169. Simmons, A., Demmrich, Y., La Vista, A., and Smith, K. (1992). Repli-cation of human herpesvirus 6 in epithelial cells in vitro. J. Infect. Dis., 166(1), 202-205.
170. Singh, N., Bentlejewski, C., Carrigan, D. R., Gayowski, T., Knox, K. K., and Zeevi, A. (2002a). Persistent lack of human herpesvirus-6 specific T-helper cell response in liver transplant recipients. Transpl. Infect. Dis., 4(2), 59-63.
171. Singh, N., Husain, S., Carrigan, D. R. et al. (2002b). Impact of human herpesvirus-6 on the frequency and severity of recur-rent hepatitis C virus hepatitis in liver transplant recipients. Clin. Transpl., 16(2), 92-96.
172. Skrinkosky, D., Hocknell, P., Whetter, L., Secchiero, P., Chandran, B., and Dewhurst, S. (2000). Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7. J. Virol., 74, 4530-4540.
173. Skrincosky, D., Willis, R. A., Hocknell, P. K. et al. (2001). Epitope map-ping of human herpesvirus-7 gp65 using monoclonal antibod-ies. Arch. Virol., 146(9), 1705-1722.
174. Smith, A., Santoro, F., Di Lullo, G., Dagna, L., Verani, A., and Lusso, P. (2003), Selective suppression of IL-12 production by human herpesvirus 6. Blood, 102(8), 2877-2884.
175. Soldan, S. S., Berti, R., Salem, N. et al. (1997), Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med., 3(12), 1394-1397.
176. Soldan, S. S., Leist, T. P., Juhng, K. N., McFarland, H. F. and Jacobson, S. (2000). Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann. Neurol., 47(3), 306-313.
177. Stefan, A., De Lillo, M., Frascaroli, G., Secchiero, P., Neipel, F., and Campadelli-Fiume, G. (1999). Development of recombi-nant diagnostic reagents based on pp85(U14) and p86(U11) proteins to detect the human immune response to human herpesvirus 7 infection. J. Clin. Microbiol., 37, 3980-3985.
178. Suga, S., Yoshikawa, T., Asano, Y., Yazaki, T., and Ozaki, T. (1990). Neutralizing antibody assay for human herpesvirus-6. J. Med. Virol., 30(1), 14-19.
179. Suga, S., Yoshikawa, T., Asano, Y. et al. (1992a). IgM neutraliz-ing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation. Microbiol. Immunol., 36(5), 495-506.
180. Suga, S., Yoshikawa, T., Asano, Y., Nakashima, T., Kobayashi, I., and Yazaki, T. (1992b). Activation of human herpesvirus-6 in chil-dren with acute measles. J. Med. Virol., 38, 278-282.
181. Takahashi, K., Sonoda, S., Higashi, K. et al.(1989). Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J. Virol., 63, 3161-3163.
182. Takaku, T., Ohyashiki, J. H., Zhang, Y., and Ohyashiki, K. (2005). Estimating immunoregulatory gene networks in human her-pesvirus type 6-infected T cells. Biochem. Biophys. Res. Com-mun., 336(2), 469-477.
183. Takahashi, K., Segal, E., Kondo, T. et al. (1992). Interferon and natu-ral killer cell activity in patients with exanthem subitum. Pedi-atr. Infect. Dis. J., 11(5), 369-373.
184. Takeda, K., Okuno, T., Isegawa, Y., and Yamanishi, K. (1996). Iden-tification of a variant A-specific neutralizing epitope on glyco-protein B (gB) of human herpesvirus-6 (HHV-6). Virology, 222, 176-183.
185. Takeda, K., Haque, M., Sunagawa, T., Okuno, T., Isegawa, Y., and Yamanishi, K. (1997). Identification of a variant B-specific neu-tralizing epitope on glycoprotein H of human herpesvirus-6. J. Gen. Virol., 78, 2171-2178.
186. Takeda, K., Haque, M., Nagoshi, E. et al. (2000). Characterization of human herpesvirus 7 U27 gene product and identification of its nuclear localization signal. Virology, 272(2), 394-401.
187. Takemoto, M., Koike, M., Mori, Y., et al. (2005). Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. J. Virol., 79(20), 13037-13046.
188. Tanaka, K., Kondo, T., Torigoe, S., Okada, S., Mukai, T., and Yaman-ishi, K. (1994). Human herpesvirus 7: Another causal agent for roseola (exanthem subitum). J. Pediatr., 125, 1-5.
189. Tanaka, H., Nishimura, T., Hakui, M., Sugimoto, H., Tanaka-Taya, K., and Yamanishi, K. (2002). Human herpesvirus 6-associated hemophagocytic syndrome in a healthy adult. Emerg. Infect. Dis., 8(1), 87-88.
190. Tejada-Simon, M. V., Zang, Y. C., Hong, J., Rivera, V. M., Killian, J. M., and Zhang, J. Z. (2002). Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J. Virol., 76(12), 6147-6154.
191. Tejada-Simon, M. V., Zang, Y. C., Hong, J., Rivera, V. M., and Zhang, J. Z. (2003). Cross-reactivity with myelin basic protein and human herpesvirus-6inmultiple sclerosis. Ann. Neurol., 53(2), 189-197.
192. Tong, C. Y., Bakran, A., Williams, H., Cheung, C. Y., and Peiris, J. S. (2000). Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Trans-plantation, 70(1), 213-216.
193. Tong, C. Y., Bakran, A., Peiris, J. S., Muir, P., and Simon, H. C. (2002). The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplanta-tion. Transplantation, 74(4), 576-578.
194. Torigoe, S., Kumamoto, T., Koide, W., Taya, K., and Yamanishi, K. (1995). Clinical manifestations associated with human her-pesvirus 7 infection. Arch. Dis. Child., 72(6), 518-519.
195. Tsukazaki, T., Yoshida, M., Namba, H., Yamada, M., Shimizu, N., and Nii, S. (1998). Development of a dot blot neutralizing assay for HHV-6 and HHV-7 using specific monoclonal antibodies. J. Virol. Methods, 73(2), 141-149.
196. Tyler, K. L. (2003). Human herpesvirus 6 and multiple sclerosis: The continuing conundrum. J. Infect. Dis., 187(9), 1360-1364.
197. Wagner, J. A., Ross, H., Gamberg, P., Valantine, H., Merigan, T. C., and Stinson, E. B. (1995). Prophylactic ganciclovir treatment reduces fungal as well ascytomegalovirus infections after heart transplantation. Transplantation, 60, 1473-1477.
198. Wang, F. Z., Dahl, H., Linde, A., Brytting, M., Ehrnst, A., and Ljung-man, P. (1996). Lymphotropic herpesviruses in allogenic bone marrow transplantation. Blood, 88, 3615-3620.
199. Wang, F. Z., Linde, A., Dahl, H., and Ljungman, P.(1999). Human her-pesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transpl., 24(11), 1201-1206.
200. Ward, K. N., Gray, J. J., Fotheringham, M. W., and Sheldon, M. J. (1993). IgG antibodies to human herpesvirus-6 in young children: Changes in avidity of antibody correlate with time after infection. J. Med. Virol., 39, 131-138.
201. Ward, K. N., Turner, D. J., Parada, X. C., and Thiruchelvam, A. D. (2001). Use of immunoglobulin G antibody avidity for differ-entiation of primary human herpesvirus 6 and 7 infections. J. Clin. Microbiol., 39(3), 959-963.
202. Ward, K. N., Couto, P. X., Passas, J., and Thiruchelvam, A. D. (2002). Evaluation of the specificity and sensitivity of indirect immunofiuorescence tests for IgG to human herpesviruses-6 and-7. J. Virol. Methods, 106(1), 107-113.
203. Wilborn, F., Brinkmann, V., Schmidt, C. A., Neipel, F., Gelderblom, H., and Siegert, W.(1994). Herpesvirustype 6inpatients under-going bone marrow transplantation: Serologic features and detection by polymerase chain reaction. Blood, 83(10), 3052-3058.
204. Wong, G. A. and Shear, N. H. (2004). Is a drug alone sufficient to cause the drug hypersensitivity syndrome? Arch. Dermatol., 140(2), 226-230.
205. Wu, C. A. and Shanley, J. D. (1998). Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J. Gen. Virol., 79, 1247-1256.
206. Wyatt, L. S. and Frenkel, N. (1992). Human herpesvirus 7 is a consti-tutive inhabitant of adult human saliva. J. Virol., 66(5), 3206-3209.
207. Wyatt, L. S., Balachandran, N., and Frenkel, N. (1990). Variations in the replication and antigenic properties of human herpesvirus 6 strains. J. Infect. Dis., 162(4), 852-857.
208. Wyatt, L. S., Rodriguez, W. J., Balachandran, N., and Frenkel, N. (1991). Human herpesvirus 7: Antigenic properties and preva-lence in children and adults. J. Virol., 65, 6260-6265.
209. Yadav, M. Umamaheswari, S., and Ablashi, D.(1991). Antibody reac-tivity with two strains of human herpesvirus-6 in Malaysians. J. Med. Virol., 33, 236-239.
210. Yakushijin, Y., Yasukawa, M., and Kobayashi, Y. (1991). T-cell immune response to human herpesvirus-6 in healthy adults. Microbiol. Immunol. 35(8), 655-660.
211. Yakushijin, Y., Yasukawa, M., and Kobayashi, Y. (1992). Establish-ment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones. J. Virol., 66(5), 2773-2779.
212. Yamamoto, M., Black, J. B., Stewart, J. A., Lopez, C., and Pellett, P. E. (1990). Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J. Clin. Microbiol., 28(9), 1957-1962.
213. Yamanishi, K., Mori, Y., and Pellett, P. E. (2007). Human her-pesviruses 6 and 7. In Fields Virology, 5th edn., Knipe et al., eds., Philadelphia: Lippincott, Williams, & Wilkins, Vol. 2, Chap. 71, in press.
214. Yasukawa, M., Yakushijin, Y., Furukawa, M., and Fujita, S. (1993). Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J. Virol., 67(10), 6259-6264.
215. Yasukawa, M., Inoue, Y., Ohminami, H., Terada, K., and Fujita, S. (1998). Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection. J. Gen. Virol., 79, 143-147.
216. Yasukawa, M., Hasegawa, A., Sakai, I. et al. (1999). Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. J. Immunol., 162(9), 5417-5422.
217. Yoshida, M., Torigoe, S., Ikeue, K., and Yamada, M. (2002a). Neu-tralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal neutraliz-ing antibodies contribute to sequential infection with these viruses in childhood. Clin. Diagn. Lab. Immunol., 9(2), 388-393.
218. Yoshida, M., Torigoe, S., and Yamada, M. (2002b). Elucidation of the cross-reactive immunoglobulin M response to human her-pesviruses 6 and 7 on the basis of neutralizing antibodies. Clin. Diagn. Lab. Immunol., 9(2), 394-402.
219. Yoshikawa, T. (2003). Human herpesvirus-6 and-7 infections in transplantation. Pediatr. Transpl., 7(1), 11-17.
220. Yoshikawa, T., Suga, S., Asano, Y. et al. (1991). Human herpesvirus-6 infection in bone marrow transplantation. Blood, 78, 1381-1384.
221. Yoshikawa, T., Ihira, M., Suzuki, K. et al. (2000). Human herpesvirus 6 infection after living related liver transplantation. J. Med. Virol., 62, 52-59.
222. Yoshikawa, T., Asano, Y., Ihira, M. et al. (2002). Human herpesvirus 6 viremia in bone marrow transplant recipients: Clinical features and risk factors. J. Infect. Dis., 185(7), 847-853.
223. Yoshikawa, T., Goshima, F., Akimoto, S. et al. (2003a). Human her-pesvirus 6 infection of human epidermal cell line: Pathogene-sis of skin manifestations. J. Med. Virol., 71(1), 62-68.
224. Yoshikawa, T., Yoshida, J., Hamaguchi, M. et al.(2003b). Humanher-pesvirus 7-associatedmeningitis and optic neuritis in a patient after allogeneic stem cell transplantation. J. Med. Virol., 70(3), 440-443.
225. Zou, P., Isegawa, Y., Nakano, K., Haque, M., Horiguchi, Y., and Yamanishi, K. (1999). Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J. Virol., 73(7), 5926-5933.